Laddar...
Quantifying the Benefits of Genome-Driven Oncology
The excitement surrounding genomically selected cancer therapy has led many to question whether this treatment paradigm is living up to its initial promise. The MOSCATO study suggests that a genome-driven strategy for cancer therapy improves outcomes in a significant minority of patients who undergo...
Sparad:
| I publikationen: | Cancer Discov |
|---|---|
| Huvudupphovsmän: | , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
2017
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5500977/ https://ncbi.nlm.nih.gov/pubmed/28576841 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/2159-8290.CD-17-0380 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|